Back
| Semester | fall semester 2018 |
| Course frequency | Every fall sem. |
| Lecturers |
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch, Assessor)
Anne Leuppi-Taegtmeyer (anne.taegtmeyer@unibas.ch) Matthias Emanuel Liechti (matthias.liechti@unibas.ch) |
| Content | 1. Drug interactions 2. Adverse drug reactions and medication errors 3. Therapeutic Drug Monitoring 4. Pregnancy 5. Dose adjustment in patients with renal or hepatic disease 6. Pharmacotherapy kin the elderly and in children 7. Pharmacogenetics and enzyme polymorphisms 8. Important intoxications, antidotes 9. Smoking and nicotine replacement 10. Alcohol 11. Bioequivalence and generics 12. Pharmacology of the skin, cutaneous adverse drug reactions 13. Swiss pharma market, regulatory approval 14. Drug dependence |
| Learning objectives | - You know the variability of kinetics and dynamics in different populations (age, organ function, genetics) and can discuss consequences for pharmacotherapy - You know the basics of TDM - You know risk factors for ADRs and important ADRs of drugs - You know the moist important drug-drug interactions - You know the basics of pharmacogenetics - You know the most important skin diseases and cutaneous ADRs - You understand the basics of addiction and know which drugs may cause it - You know the problematics of alcohol and nicotine abuse - You know the most important inxications in humans - You know the principles of the Swiss drug market and understand the approval process. You know what generics and biosimilars are - Sie können die wichtigsten Ursachen der Adipositas und können die entsprechende Pharmakotherapie diskutieren - Sie kennen die Klinik der wichtigsten Intoxikationen sowie die dafür notwendigen Antidota - Sie können Therapieansätze und Pharmakotherapie des Nikotin- und Alkoholabusus diskutieren - Sie können die Grundsätze der Bioäquivalenz nennen und diskutieren - Sie kennen die wichtigsten dermatologischen Erkrankungen und deren Therapie |
| Bibliography | 1. Goodman & Gilmans The Pharmacological Basis of Therapeutics. McGraw-Hill. Newest edition. 2. Herdegen T. Kurzlehrbuch Pharmakologie und Toxikologie. Thieme Verlag. Newest edition. |
| Comments | Film and sound recordings during the course are strictly forbidden (recorders may be confiscated) |
| Weblink | ADAM |
| Admission requirements | |
| Language of instruction | English |
| Use of digital media | No specific media used |
| Interval | Weekday | Time | Room |
|---|
No dates available. Please contact the lecturer.
| Modules |
Electives Master Science in Pharmacy: Recommendations (Master's Studies: Science in Pharmacy) Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences) |
| Assessment format | continuous assessment |
| Assessment details | vgl. https://pharma.unibas.ch/de/teaching/pruefungen-exams/performance-assessments/course-accompanying-examinations/ |
| Assessment registration/deregistration | Reg.: course registration, dereg: cancel course registration |
| Repeat examination | no repeat examination |
| Scale | 1-6 0,5 |
| Repeated registration | as often as necessary |
| Responsible faculty | Faculty of Science, studiendekanat-philnat@unibas.ch |
| Offered by | Departement Pharmazeutische Wissenschaften |